SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-24-000145
Filing Date
2024-01-30
Accepted
2024-01-30 08:00:09
Documents
19
Period of Report
2024-01-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nhwk_8k.htm   iXBRL 8-K 34957
2 CONVERTIBLE PROMISSORY NOTE ex4x1.htm EX-4.1 66715
3 PATENT RIGHTS SALE AND ASSIGNMENT AGREEMENT ex10x1.htm EX-10.1 31613
4 PRESS RELEASE ex99x1.htm EX-99.1 8284
5 GRAPHIC image_001.jpg GRAPHIC 10182
  Complete submission text file 0001079973-24-000145.txt   401583

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nhwk-20240126.xsd EX-101.SCH 3534
7 XBRL DEFINITION FILE nhwk-20240126_def.xml EX-101.DEF 26569
8 XBRL LABEL FILE nhwk-20240126_lab.xml EX-101.LAB 36527
9 XBRL PRESENTATION FILE nhwk-20240126_pre.xml EX-101.PRE 25193
20 EXTRACTED XBRL INSTANCE DOCUMENT nhwk_8k_htm.xml XML 5435
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 24575904
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)